Phase I Study of HBT-708 for Patients With Advanced Solid Tumors

Clinical trial NCT06993870 · RECRUITING

Trial details

NCT number: NCT06993870
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-06-16
Primary completion: 2026-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.